Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024. In the quarter to June 2026, revenue grew 5.15%, EPS fell 920.0%, free cash flow grew 28.6% and total debt fell 25.1%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five.
Follow BRKR
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
500.30 | 439.20 | 322.40 | 684.90 | 731.80 | 1,168.20 | 645.50 | 488.30 | 183.40 | 298.80 |
Receivables |
243.90 | 319.30 | 357.20 | 362.20 | 335.30 | 416.90 | 472.70 | 492.00 | 565.50 | 544.90 |
Inventory |
440.40 | 486.20 | 509.60 | 577.20 | 692.30 | 710.10 | 800.10 | 968.30 | 1,067.80 | 1,094.60 |
Other current assets |
91.30 | 114.10 | 115.10 | 172.00 | 165.60 | 176.60 | 194.90 | 215.60 | 236.50 | 274.20 |
Total current assets |
1,275.90 | 1,358.80 | 1,304.30 | 1,796.30 | 1,925.00 | 2,471.80 | 2,113.20 | 2,164.20 | 2,053.20 | 2,212.50 |
Property, Plant, Equpment (Net) |
239.10 | 266.50 | 270.60 | 306.10 | 395.50 | 406.10 | 487.00 | 599.70 | 669.30 | 744.80 |
Goodwill and Intangible Assets (Total) |
200.30 | 252.20 | 494.40 | 526.20 | 549.50 | 551.30 | 728.50 | 913.10 | 2,419.80 | 2,447.30 |
Long Term Assets (Tax, Deferred) |
76.50 | 57.00 | 50.90 | 60.50 | 72.00 | 90.10 | 76.80 | 297.20 | 286.20 | 421.70 |
Long-term assets (Other) |
16.60 | 14.00 | 8.40 | 16.80 | 39.60 | 70.80 | 155.10 | 184.00 | 232.70 | 249.30 |
Total non-current assets |
532.50 | 589.70 | 824.30 | 975.20 | 1,124.00 | 1,178.20 | 1,498.60 | 2,085.70 | 3,753.50 | 4,028.90 |
Total Assets |
1,808.40 | 1,948.50 | 2,128.60 | 2,771.50 | 3,049.00 | 3,650.00 | 3,611.80 | 4,249.90 | 5,806.70 | 6,241.40 |
Accounts Payable |
86.10 | 90.80 | 104.50 | 118.40 | 134.60 | 147.40 | 178.40 | 202.70 | 234.10 | 215.90 |
Current Part of Debt |
20.10 | — | 18.50 | 0.50 | 2.20 | 112.40 | 18.70 | 121.20 | 32.50 | 16.60 |
Current Revenue (Deferred) |
— | — | — | — | — | — | — | 400.00 | 438.20 | 441.30 |
Other current liabilities |
418.50 | 433.70 | 476.30 | 526.70 | 655.10 | 678.70 | 717.20 | 478.20 | 576.50 | 605.40 |
Total current liabilities |
524.70 | 524.50 | 599.30 | 645.60 | 791.90 | 938.50 | 914.30 | 1,202.10 | 1,281.30 | 1,279.20 |
Long Term Debt (Total) |
391.60 | 415.60 | 322.60 | 812.80 | 842.30 | 1,221.80 | 1,200.50 | 1,160.30 | 2,061.80 | 1,852.50 |
Non-current Revenue (Deferred) |
46.80 | 48.70 | 38.30 | 42.80 | 50.90 | 50.20 | 101.60 | 91.50 | 100.00 | 109.10 |
Pension and Post-Retirement Liabilities |
102.50 | 105.60 | 90.50 | 122.40 | 123.40 | 104.70 | 45.70 | 76.60 | — | — |
Long Term Tax Liability (Deferred) |
10.10 | 24.30 | 51.10 | 48.80 | 43.10 | 46.00 | 62.30 | 67.70 | 118.50 | 112.50 |
Minority Interests |
— | — | 22.60 | 21.10 | 0.00 | 0.20 | 6.10 | 18.70 | 18.10 | 36.80 |
Non-current Liabilities (Other) |
39.60 | 96.30 | 99.10 | 113.90 | 176.10 | 162.20 | 120.80 | 240.20 | 311.00 | 239.20 |
Total non-current liabilities |
590.60 | 690.50 | 624.20 | 1,208.80 | 1,282.80 | 1,626.90 | 1,571.80 | 1,653.20 | 2,728.30 | 2,488.70 |
Total liabilities |
1,115.30 | 1,215.00 | 1,223.50 | 1,854.40 | 2,074.70 | 2,565.40 | 2,486.10 | 2,855.30 | 4,009.60 | 3,767.90 |
Additional Paid In Capital |
124.70 | 155.90 | 176.90 | 199.70 | 216.30 | 237.80 | 256.30 | 282.90 | 713.40 | 1,414.60 |
Common Stock (Net) |
1.70 | 1.70 | 1.70 | 1.70 | 1.70 | 1.70 | 1.70 | 1.70 | 1.80 | 1.80 |
Retained Earnings |
885.20 | 942.00 | 1,102.50 | 1,274.70 | 1,406.50 | 1,659.50 | 1,926.00 | 2,323.80 | 2,406.70 | 2,361.80 |
Treasury Stock |
249.30 | 401.20 | 401.50 | 543.80 | 667.00 | 820.30 | 1,085.00 | 1,237.20 | 1,237.20 | 1,242.20 |
Common Equity (Total) |
693.10 | 733.50 | 905.10 | 917.10 | 974.30 | 1,084.60 | 1,125.70 | 1,394.60 | 1,797.10 | 2,473.50 |
Shareholders Equity (Total) |
693.10 | 733.50 | 905.10 | 917.10 | 974.30 | 1,084.60 | 1,125.70 | 1,394.60 | 1,797.10 | 2,473.50 |
Shareholders Equity and Liabilities (Total) |
1,808.40 | 1,948.50 | 2,128.60 | 2,771.50 | 3,049.00 | 3,650.00 | 3,611.80 | 4,249.90 | 5,806.70 | 6,241.40 |
Shares (Common) |
159.85 | 155.87 | 156.61 | 154.16 | 151.99 | 150.75 | 147.02 | 145.16 | 151.68 | 152.14 |
Shareholders Equity (Tangible) |
492.80 | 481.30 | 410.70 | 390.90 | 424.80 | 533.30 | 397.20 | 481.50 | (622.70) | 26.20 |
Net Debt |
(88.60) | (23.60) | 18.70 | 128.40 | 112.70 | 166.00 | 573.70 | 793.20 | 1,910.90 | 1,570.30 |
Total Debt |
411.70 | 415.60 | 341.10 | 813.30 | 844.50 | 1,334.20 | 1,219.20 | 1,281.50 | 2,094.30 | 1,869.10 |